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Introduction: Left sided low-level vagus nerve stimulation (LL-VNS) is used clinically for epilepsy 
and depression. We hypothesize that LL-VNS can suppress sympathetic outflow and reduce 
atrial tachyarrhythmias in ambulatory dogs.  
 
Methods: We implanted in 12 dogs a neurostimulator in left cervical vagus nerve and a 
radiotransmitter for continuous recording of left stellate ganglion nerve activities (SGNA), left 
thoracic vagal nerve activities (VNA) and electrocardiograms. The first 6 dogs (Group 1) 
underwent 1 week continuous LL-VNS. Another 6 dogs (Group 2) underwent intermittent rapid 
atrial pacing followed by active or sham LL-VNS on alternate weeks.  
 
Results: Integrated SGNA was significantly reduced during LL-VNS (7.8±0.9 mV-s vs. 9.4±0.9 mV-
s at baseline, P<0.05) in Group 1.The reduction was most apparent from 7 to 9 AM, (31% 
reduction, 10.8±2.5 mV-s versus 15.6±2.9 mV-s at baseline, P<0.01), along with a significantly 
reduced heart rate (P<0.05). SGNA-induced heart rate acceleration averaged 107.9±9.0 bpm 
during LL-VNS and 129.2±9.3 bpm at baseline (P<0.05). LL-VNS did not change VNA. The 
tyrosine hydroxylase-positive nerve structures in the left stellate ganglion were 99,684±22,257 
µm2/mm2 in LL-VNS dogs and 186,561±11,383 µm2/mm2 (P<0.01) in normal control dogs. In 
Group 2, the frequencies of paroxysmal atrial fibrillation and atrial tachycardia during active LL-
VNS were 1.4±2.5/d and 8.0±5.8/d, respectively, significantly lower than during sham 
stimulation (9.2±6.2/d, P<0.01 and 22.0±4.4/d, P<0.001, respectively).   
 
Conclusion: LL-VNS suppresses SGNA and reduces the incidences of paroxysmal atrial 
tachyarrhythmias in ambulatory dogs. Significant neural remodeling of the left stellate ganglion 
is evident one week after cessation of chronic LL-VNS. 
 
